Search Results for: DNR
As the long holiday weekend rolls in, we thought we’d take a look at some oil, gas, and energy services stocks that might offer good value in the medium term. We’ve focused on five oil and gas...
Published:
Last Updated:
Yesterday, the energy sector gained 1.69%, as money flowed into ExxonMobil (NYSE:XOM), up 2.63%; ConocoPhillips (NYSE:COP), up 3.07%, Transocean (NYSE:RIG), up 3.21%; and Apache (NYSE:APA), up 6.04%....
Published:
There are a wide variety of REITs involved in non-residential property ownership and management and a few of these are our focus today. These include general office space, technology company office...
Published:
Genentech (NYSE:DNA) posted $0.73 EPS vs $0.72 estimates, but revenues were $2.95 Billion versus a $2.93 Billion estimate. It looks like 3 of the 4 major drugs came in under expectations, with...
Published:
Last Updated:
Roche has apparently capitulated in its fight to take over Genentech Inc. (NYSE: DNA). Its cancer franchise and its pipeline, along with a shareholder proxy fight, finally made Roche tip its...
Published:
Last Updated:
Source: Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Friday.Dean Foods Company (NYSE: DF) Cut to Neutral at Goldman...
Published:
Last Updated:
Genentech’s (DNA) for Q2 hit $3 billion, up from $2.2 billion in the same quarter last year. Operating income hit $1.1 billion up from $.75 billion last year. Big winners in the company’s...
Published:
Genentech Inc. (NYSE: DNA) is initially looking like a severe disappointment to those who thought Cramer’s call last week was the right one. The largest biotech in the U.S. posted $0.82...
Published:
Genentech, Inc. (NYSE:DNA) has announced that the biotech giant has authorized the extension of its current stock repurchase program through June 30, 2009 and it amended the current repurchase...
Published:
Last Updated:
After today’s close, we are expecting the earnings report of of biotech giant Genentech, Inc. (NYSE: DNA). First Call estimates are for $0.88 EPS on $3.36 billion in revenue. Today is going to...
Published:
Last Updated:
Western Refining Inc. (NYSE:WNR) reported a quarterly EPS loss of -$0.19, just half as much as its -$0.38 EPS loss in the fourth quarter of 2007. Excluding a one-time inventory write-down, the...
Published:
Dune Energy, Inc. (Amex: DNE) is selling off its Barnett Shale assets located in Denton and Wise Counties, Texas, for $41.5 million. The effective date of the sale will be May 1, 2008, with...
Published:
Source: ThinkstockD.R. Horton Inc. (NYSE: DHI) reported third-quarter fiscal 2013 earnings before markets opened this morning. The home builder posted diluted earnings per share (EPS) of $0.42 on...
Published:
Last Updated:
The board of Genentech (DNA) turned down an $86.50 offer by Roche to buy the part of the company that it does not already own. Until about a month ago, the offer had been higher–$89. Sponsored:...
Published:
Last Updated:
Genentech (DNA) announced that a new study uncovered that fact that its Avastin cancer drug can improve survival among people with severe lung cancer when it is added to other treatments. It is good...
Published: